Author:
Hammel Basma,Michel Martin C.
Publisher
Springer International Publishing
Reference29 articles.
1. Bauer P, Köhne K (1994) Evaluation of experiments with adaptive interim analysis. Biometrics 50:1029–1041
2. Cure S, Guerra I, Dusheiko G (2015) Cost-effectiveness of sofosbuvir for the treatment of chronic hepatitis C-infected patients. J Viral Hepat 22:882–889
3. European Medicines Agency (2017) European Medicines Agency guidance for applicants seeking scientific advice and protocol assistance.
https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/european-medicines-agency-guidance-applicants-seeking-scientific-advice-protocol-assistance_en.pdf
. Accessed 30 July 2019
4. European Medicines Agency and eunethta (2019) Guidance for parallel consultation.
https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/guidance-parallel-consultation_en.pdf
. Accessed 30 July 2019
5. Fridlyand J, Simon RM, Walrath JC, Roach N, Buller R, Schenkein DP, Flaherty KT, Allen JD, Sigal EV, Scher HI (2013) Considerations for the successful co-development of targeted cancer therapies and companion diagnostics. Nat Rev Drug Discov 12:743–755
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献